BDC Capital | Life Sciences Venture Fund

vc$900MCo-investsLeads rounds

◆ Fund Size

$900M

◆ Check Size

$0.7M→$6.0M

◆ Location

Canada

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Aimed at supporting early-stage companies in therapeutics and medical technologies to help them transition from research and development to commercialization, addressing funding gaps and retaining scientific talent in Canada.

◆ About BDC Capital

BDC Capital's Life Sciences Venture Fund is a $150 million CAD fund targeting seed- and early-stage (Series A) Canadian companies in therapeutics and medical technologies. It provides patient capital to address funding gaps in capital-intensive sectors requiring hardware and regulatory approvals. The fund aims to back 10-15 companies, accelerating their path from lab to market.

◆ Sectors

BiotechMedtechDrug Discovery

◆ Stages

pre-seedseedseries-a

◆ Geography Focus

Canada

◆ Notable Investments

Growth Venture Fund (late-stage innovation-based Canadian businesses)Growth Equity Partners fund/programIT Venture FundSeed Venture FundCanadian technology innovators across software, AI, digital health, and climate technology

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Life Sciences Venture Fund invest in?

Life Sciences Venture Fund invests in Biotech, Medtech and Drug Discovery at the pre-seed, seed and series-a stages.

Which geographies does Life Sciences Venture Fund focus on?

Life Sciences Venture Fund focuses on Canada, and is headquartered in Canada.

What is Life Sciences Venture Fund's typical check size?

Life Sciences Venture Fund typically writes checks of $0.7M to $6M.